Rvnc alert: thornton law firm reminds revance therapeutics investors of securities class action

Boston, massachusetts--(newsfile corp. - february 1, 2022) - the thornton law firm reminds investors that a class action lawsuit has been filed on behalf of investors of revance therapeutics, inc. (nasdaq: rvnc). the case is currently in the lead plaintiff stage. investors who purchased rvnc securities between november 25, 2019 and october 11, 2021 may contact the thornton law firm's investor protection team by visiting www.tenlaw.com/cases/revance-therapeutics-inc for more information. investors may also email investors@tenlaw.com or...
RVNC Ratings Summary
RVNC Quant Ranking